{"product_id":"meriscreen-dengue-onset-combo-10t","title":"MERISCREEN® Dengue Onset Combo Rapid Test Kit — NS1 Ag + IgG\/IgM (10T)","description":"\u003ch2\u003eMERISCREEN® Dengue Onset — Complete Dengue Diagnosis From Day 1 in a Single Kit\u003c\/h2\u003e\n\n\u003cp\u003eMERISCREEN® Dengue Onset is a \u003cstrong\u003e3-in-1 rapid combo test\u003c\/strong\u003e that combines NS1 Antigen detection with IgG\/IgM antibody differentiation in a single kit — providing complete dengue diagnostic coverage \u003cstrong\u003efrom Day 1 of fever through convalescence\u003c\/strong\u003e. One kit, one patient, one definitive answer across all stages of infection.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDengue Onset = Dengue NS1 Ag + Dengue IgG\/IgM Ab\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch3\u003eWhy a Combo Test?\u003c\/h3\u003e\n\n\u003cp\u003eDengue presents a diagnostic challenge because different markers appear at different stages. NS1 antigen is detectable from \u003cstrong\u003eDay 1 through Day 9\u003c\/strong\u003e, while IgM antibodies appear from \u003cstrong\u003eDay 5 onwards\u003c\/strong\u003e and IgG from \u003cstrong\u003eDay 14 (primary) or Day 2 (secondary)\u003c\/strong\u003e. Patients rarely present on a predictable day of illness — a combo test eliminates the guesswork by covering the entire diagnostic window simultaneously. This is especially critical during peak season when fever clinics see hundreds of patients daily and need rapid, one-shot answers.\u003c\/p\u003e\n\n\u003ch3\u003eHow It Works\u003c\/h3\u003e\n\n\u003cp\u003eEach test set contains \u003cstrong\u003etwo cassettes\u003c\/strong\u003e — one for NS1 antigen detection (using monoclonal antibody capture and colloidal gold conjugate) and one for IgG\/IgM antibody differentiation (using GAC and MAC principles with recombinant dengue envelope proteins). Both cassettes use the same assay buffer. Add 90–100 µL serum\/plasma to the NS1 device via dropper, and 5 µL to the IgG\/IgM device via capillary tube. Read results at 20 minutes. All four serotypes (DEN-1, DEN-2, DEN-3, DEN-4) are detected across both cassettes.\u003c\/p\u003e\n\n\u003ch3\u003eKey Advantages\u003c\/h3\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eComplete Coverage:\u003c\/strong\u003e Detects dengue at every stage — NS1 for acute phase (Day 1–9), IgM for primary infection (Day 5+), IgG for secondary infection (Day 2+)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrimary vs. Secondary Differentiation:\u003c\/strong\u003e Dual antibody lines distinguish primary dengue (IgM dominant) from secondary dengue (IgG dominant) — critical for DHF\/DSS risk stratification\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAll 4 Serotypes:\u003c\/strong\u003e Both cassettes detect DEN-1, DEN-2, DEN-3, DEN-4\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCost-Effective:\u003c\/strong\u003e Single combo kit replaces purchasing NS1 and IgG\/IgM kits separately — saves procurement cost and storage space\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRapid Results:\u003c\/strong\u003e Both results in 20 minutes — no instruments, no electricity\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh Performance:\u003c\/strong\u003e Sensitivity ≥95%, Specificity ≥95% on both cassettes\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRobust Storage:\u003c\/strong\u003e 2–30°C — no cold chain dependency\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eClinical Applications\u003c\/h3\u003e\n\n\u003cul\u003e\n\u003cli\u003eFirst-line diagnostic in fever OPDs and emergency departments — one kit answers \"Is it dengue?\" and \"Primary or secondary?\" simultaneously\u003c\/li\u003e\n\u003cli\u003eHigh-throughput screening during dengue season (July–November) — reduces per-patient test turnaround\u003c\/li\u003e\n\u003cli\u003eClinical triage for DHF\/DSS risk — secondary infections (IgG+) carry higher risk of hemorrhagic complications\u003c\/li\u003e\n\u003cli\u003ePathology labs and diagnostic chains seeking a single-SKU dengue solution\u003c\/li\u003e\n\u003cli\u003eGovernment NVBDCP surveillance and outbreak response\u003c\/li\u003e\n\u003cli\u003ePHCs and rural health centers where stocking multiple separate kits is impractical\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eDiagnostic Window Coverage\u003c\/h3\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDay of Illness\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eNS1 Ag\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eIgM Ab\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eIgG Ab (Primary)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eIgG Ab (Secondary)\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDay 1–4\u003c\/td\u003e\n\u003ctd\u003e✅ Detectable\u003c\/td\u003e\n\u003ctd\u003e❌ Not yet\u003c\/td\u003e\n\u003ctd\u003e❌ Not yet\u003c\/td\u003e\n\u003ctd\u003e✅ Day 2+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDay 5–9\u003c\/td\u003e\n\u003ctd\u003e✅ Detectable\u003c\/td\u003e\n\u003ctd\u003e✅ Appears\u003c\/td\u003e\n\u003ctd\u003e❌ Not yet\u003c\/td\u003e\n\u003ctd\u003e✅ Rising\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDay 10–14\u003c\/td\u003e\n\u003ctd\u003e⚠️ Declining\u003c\/td\u003e\n\u003ctd\u003e✅ Peak\u003c\/td\u003e\n\u003ctd\u003e✅ Appears\u003c\/td\u003e\n\u003ctd\u003e✅ High\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDay 15+\u003c\/td\u003e\n\u003ctd\u003e❌ Gone\u003c\/td\u003e\n\u003ctd\u003e✅ Persists 30–60d\u003c\/td\u003e\n\u003ctd\u003e✅ Persists\u003c\/td\u003e\n\u003ctd\u003e✅ Persists\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cem\u003eThe Dengue Onset combo covers every row in this table — no diagnostic blind spots.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch3\u003eProduct Specifications\u003c\/h3\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSKU\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRPDDON-01\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePack Size\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e10 Tests (10 NS1 cassettes + 10 IgG\/IgM cassettes)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAssay Format\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDual-Cassette Rapid Immunochromatographic Assay (Lateral Flow)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDetection Targets\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNS1 Antigen + Anti-Dengue IgG (GAC) + Anti-Dengue IgM (MAC)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSerotype Coverage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDEN-1, DEN-2, DEN-3, DEN-4\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSample Type\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSerum, Plasma\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSample Volume\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNS1: 90–100 µL (dropper) | IgG\/IgM: 5 µL (capillary tube)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAssay Buffer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e4 drops (shared buffer for both cassettes)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResult Time\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e20 minutes\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSensitivity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSpecificity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e2–30°C (no cold chain required)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHSN Code\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e3006\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eGST\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e5% (inclusive in listed price)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eManufacturer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eMeril Diagnostics Pvt. Ltd., India\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch3\u003eKit Contents\u003c\/h3\u003e\n\n\u003cul\u003e\n\u003cli\u003e10 NS1 Ag test cassettes (individually sealed)\u003c\/li\u003e\n\u003cli\u003e10 IgG\/IgM Ab test cassettes (individually sealed)\u003c\/li\u003e\n\u003cli\u003e10 droppers (for NS1) + 10 capillary tubes (for IgG\/IgM)\u003c\/li\u003e\n\u003cli\u003e2 bottles assay buffer (shared)\u003c\/li\u003e\n\u003cli\u003e1 package insert \/ IFU\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eInterpretation Guide\u003c\/h3\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eNS1 Result\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eIgG\/IgM Result\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eInterpretation\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNS1 Positive\u003c\/td\u003e\n\u003ctd\u003eIgM\/IgG Negative\u003c\/td\u003e\n\u003ctd\u003eEarly acute dengue (Day 1–4) — active viremia, monitor platelet count\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNS1 Positive\u003c\/td\u003e\n\u003ctd\u003eIgM Positive\u003c\/td\u003e\n\u003ctd\u003eAcute primary dengue — seroconversion underway\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNS1 Positive\u003c\/td\u003e\n\u003ctd\u003eIgG Positive\u003c\/td\u003e\n\u003ctd\u003eAcute secondary dengue — HIGH DHF\/DSS risk, close monitoring\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNS1 Negative\u003c\/td\u003e\n\u003ctd\u003eIgM Positive\u003c\/td\u003e\n\u003ctd\u003ePrimary dengue, post-viremic phase (Day 5+)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNS1 Negative\u003c\/td\u003e\n\u003ctd\u003eIgG + IgM Positive\u003c\/td\u003e\n\u003ctd\u003eSecondary dengue, convalescent — monitor for DHF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNS1 Negative\u003c\/td\u003e\n\u003ctd\u003eIgG Positive only\u003c\/td\u003e\n\u003ctd\u003ePast dengue exposure or late secondary infection\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNS1 Negative\u003c\/td\u003e\n\u003ctd\u003eAll Negative\u003c\/td\u003e\n\u003ctd\u003eDengue unlikely — consider other differentials\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch3\u003eWhy Buy From Agile Healthcare?\u003c\/h3\u003e\n\n\u003cul\u003e\n\u003cli\u003eAuthorized Meril Diagnostics master distributor — genuine stock with batch traceability\u003c\/li\u003e\n\u003cli\u003eGST-inclusive pricing — no hidden charges\u003c\/li\u003e\n\u003cli\u003eVolume discounts: 10% off at 5+ boxes, 18% off at 10+, 27% off at 25+\u003c\/li\u003e\n\u003cli\u003ePan-India delivery within 3–5 business days\u003c\/li\u003e\n\u003cli\u003eTechnical support and application training available\u003c\/li\u003e\n\u003cli\u003eCertificate of Analysis (CoA) available on request\u003c\/li\u003e\n\u003cli\u003eAlso available separately: \u003ca href=\"\/products\/meriscreen-dengue-ns1-ag-10t\"\u003eNS1 Ag (RPDDAG-01)\u003c\/a\u003e and \u003ca href=\"\/products\/meriscreen-dengue-igg-igm-20t\"\u003eIgG\/IgM (RPDDAB-01)\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Meril Diagnostics","offers":[{"title":"10T","offer_id":52011693834560,"sku":"RPDDON-01","price":1100.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0962\/2231\/4816\/files\/Gemini_Generated_Image_uxbgyxuxbgyxuxbg.png?v=1780210359","url":"https:\/\/agilehealthcare.shop\/products\/meriscreen-dengue-onset-combo-10t","provider":"My Store","version":"1.0","type":"link"}